John M. Warrington

Washington University in St. Louis — United States

Medicine · Health Sciences

8h-index429citations35works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(23), vaccines and immunoinformatics approaches(15), Transgenic Plants and Applications(9), Immunotherapy and Immune Responses(8), Immune Cell Function and Interaction(7)

Publications35 total

BACH2 regulates T cell lineage state to enhance CAR T cell function
Nature Immunology·2026· 2 cited
BACH2 regulates T cell lineage states to overcome dysfunction driven by tonic CAR signaling
Blood·2025· 1 citedOpen Access
Disarming myeloid resistance in CAR T therapy
Cancer Cell·2025
BACH2 regulates T cell lineage states to overcome dysfunction driven by tonic CAR signaling
2025· 1 citedOpen Access
Supplementary Figure 1 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 7 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 2 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 3 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 8 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 4 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 6 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Supplementary Figure 5 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Data from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024Open Access
Regulatory Considerations for Genome-Edited T-cell Therapies
Cancer Immunology Research·2024· 7 citedOpen Access
Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
Cancer Discovery·2024· 9 citedOpen Access
Rational protein engineering to enhance MHC-independent T cell receptors
2024Open Access
Targeting of intracellular oncoproteins with peptide-centric CARs
Nature·2023· 65 citedOpen Access
Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
Nature·2023· 1 citedOpen Access
Regulation of the Transcriptional Repressor BACH2 Overcomes Tonic Signaling-Driven CAR T Cell Dysfunction
Blood·2023· 1 citedOpen Access
Enhancing MHC-Independent T Cell Receptors Using Rational Protein Engineering
Blood·2023
page 1 of 2Next →

Frequent Co-authors

Jack H. Landmann(19), Mehmet Emrah Selli(19), Yu-Sung Hsu(18), Tien-Ching Chang(18), Nathan Singh(17), Michael Slade(14), Julie Ritchey(14), Deepesh Kumar Gupta(14), John F. DiPersio(14), Yangdon Tenzin(13), Ju-Fang Chang(12), Alex S. Holehouse(10), Mark Yarmarkovich(9), John M. Maris(9), Alvin Farrel(8), Amanda Heard(7), Jufang Chang(7), John Lattin(5), Quinlen F. Marshall(4), Moreno Di Marco(4)